Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „monotherapy“
Suchtreffer
Begriffe & Kennungen
Abraxane · 4.5 · Abraxane is indicated as monotherapy for breast cancer, in combination with gemcitabine for pancreatic adenoca
Eintrag öffnenAbraxane · 4.8 · 10 Monotherapy (N = 789) Combination therapy Combination therapy with gemcitabine with carboplatin (N = 421) (
Eintrag öffnenAbraxane · 4.8 · 11 Monotherapy (N = 789) Combination therapy Combination therapy with gemcitabine with carboplatin (N = 421) (
Eintrag öffnenAbraxane · 4.8 · 12 Monotherapy (N = 789) Combination therapy Combination therapy with gemcitabine with carboplatin (N = 421) (
Eintrag öffnenAbraxane · 4.8 · 13 Monotherapy (N = 789) Combination therapy Combination therapy with gemcitabine with carboplatin (N = 421) (
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer Alopecia was observed in > 80% of the patients treated with Abra
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer Arthralgia occurred in 32% of patients on Abraxane and was sever
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer Asthenia/Fatigue was reported in 40% of the patients.
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer In general, the frequency and severity of neurotoxicity was dose
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer In patients with metastatic breast cancer, neutropenia was the m
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer Nausea occurred in 29% of the patients and diarrhoea in 25% of t
Eintrag öffnenAbraxane · 4.8 · Table 6 lists adverse reactions associated with Abraxane monotherapy at any dose in any indication during clin
Eintrag öffnenAbraxane · 4.8 · Table 6: Adverse reactions reported with Abraxane Monotherapy (N = 789) Combination therapy Combination therap
Eintrag öffnenAbraxane · 4.8 · monotherapy for breast cancer and for other indications. 3 Based on laboratory assessments: maximal degree of
Eintrag öffnenAdcetris · 4.8 · 15 System organ class Adverse reactions (monotherapy) Adverse reactions (combination therapy) Not known: Progr
Eintrag öffnenAdcetris · 4.8 · In the pooled dataset of ADCETRIS as monotherapy across HL, sALCL and CTCL studies (SG035-0003, SG035-0004, SG
Eintrag öffnenAdcetris · 4.8 · Monotherapy
Eintrag öffnenAdcetris · 4.8 · Monotherapy Study C25002
Eintrag öffnenAdcetris · 4.8 · System organ class Adverse reactions (monotherapy) Adverse reactions (combination therapy) Infections and infe
Eintrag öffnenAdtralza · 4.8 · The long-term safety of tralokinumab was assessed in 2 monotherapy studies up to 52 weeks, and in a combinatio
Eintrag öffnen